While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.
Scientists survey how the mpox virus spreads through populations, the immunology of infections and current treatment interventions.
Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to mRNA-based vaccines.
A new analytical platform reveals signature changes in immune cells of the brain during aging and neurodegenerative conditions such as Alzheimer’s disease.
Vaccinated people affected by COVID-19 variants have different memory B cell responses than their close contacts who remain healthy.
A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.
A novel molecular mechanism by which a malarial parasite enters host cells may broaden possibilities in malaria vaccine development.
The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.
A new link between gene variations in immune cells and allergic reactions explains why some individuals are more prone to developing asthma.
New research techniques are enabling scientists like SIgN’s Florent Ginhoux to unravel the complexities of the immune system like never before.
Maternal antibodies can cross the placenta and pass on mother’s allergies to her children in the womb.